Figure 1.
Effects of myricetin on cardiac function and serum marker levels in HIE. (A) Representative M-mode echocardiograms; (B) ejection fraction (EF%) values; (C) left-ventricular short-axis shortening (FS%) values; (D) AST; (E) LDH; (F) CK; (G) CK-MB; and (H) mouse serum troponin I (cTnI). The data are presented as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, and ns represents no statistical difference.